Caffeic Acid Phenethyl Ester Suppresses the Proliferation of Human Prostate Cancer Cells through Inhibition of p70S6K and Akt Signaling Networks
- 1 May 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 5 (5), 788-797
- https://doi.org/10.1158/1940-6207.capr-12-0004-t
Abstract
Caffeic acid phenethyl ester (CAPE) is a bioactive component derived from honeybee hive propolis. CAPE has been shown to have antimitogenic, anticarcinogenic, and other beneficial medicinal properties. Many of its effects have been shown to be mediated through its inhibition of NF-κB signaling pathways. We took a systematic approach to uncover the effects of CAPE from hours to days on the signaling networks in human prostate cancer cells. We observed that CAPE dosage dependently suppressed the proliferation of LNCaP, DU-145, and PC-3 human prostate cancer cells. Administration of CAPE by gavage significantly inhibited the tumor growth of LNCaP xenografts in nude mice. Using LNCaP cells as a model system, we examined the effect of CAPE on gene expression, protein signaling, and transcriptional regulatory networks using micro-Western arrays and PCR arrays. We built a model of the impact of CAPE on cell signaling which suggested that it acted through inhibition of Akt-related protein signaling networks. Overexpression of Akt1 or c-Myc, a downstream target of Akt signaling, significantly blocked the antiproliferative effects of CAPE. In summary, our results suggest that CAPE administration may be useful as an adjuvant therapy for prostate and potentially other types of cancers that are driven by the p70S6K and Akt signaling networks. Cancer Prev Res; 5(5); 788–97. ©2012 AACR.Keywords
Other Versions
This publication has 54 references indexed in Scilit:
- Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approachesExpert Review of Proteomics, 2011
- Androgen suppresses proliferation of castration‐resistant LNCaP 104‐R2 prostate cancer cells through androgen receptor, Skp2, and c‐MycCancer Science, 2011
- TFM-Explorer: mining cis-regulatory regions in genomesNucleic Acids Research, 2010
- Systems analysis of EGF receptor signaling dynamics with microwestern arraysNature Methods, 2010
- Caffeic acid phenethyl ester inhibits nuclear factor-κB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cellsClinical and Experimental Immunology, 2010
- Maspin Suppresses Survival of Lung Cancer Cells through Modulation of Akt PathwayCancer Research and Treatment, 2010
- Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cellsCancer Letters, 2009
- The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cellsBiochemical and Biophysical Research Communications, 2007
- The Stress-activated Protein Kinases p38α and JNK1 Stabilize p21Cip1 by PhosphorylationOnline Journal of Public Health Informatics, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999